Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns the liver into a short‑lived factory for powerful T‑cell survival signals.

Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand ...